Nour Drai
About Nour Drai
Nour Drai is the HTA and Market Access Manager at Bristol Myers Squibb in Montreal, Quebec, Canada.
Title and Current Position
Nour Drai currently holds the position of HTA and Market Access Manager at Bristol Myers Squibb. This role is based in Montreal, Quebec, Canada. She took on this role in July 2021, where she is involved in health technology assessment (HTA) and market access tasks.
Previous Roles and Experience
Nour Drai has a diverse professional background in the pharmaceutical and healthcare sectors. She worked at the Institut national d'excellence en santé et en services sociaux (INESSS) as a Scientific Advisor in Pharmacoeconomics from 2018 to 2021. Prior to that, she was involved in Health Economics and Patient Access at Novartis for 11 months in 2017-2018. She also gained experience in medical information at Pfizer in 2015 for 8 months.
Educational Background
Nour Drai has an extensive academic background. She earned a Master's degree in Drug Development/Pharmaceutical Sciences from Université de Montréal, studying at the institution from 2016 to 2018. Additionally, she holds a Bachelor's degree in Biopharmaceutics from the Université de Montréal, which she completed from 2012 to 2015. Earlier, she obtained a DEC in Natural Sciences from Collège de Bois-De-Boulogne from 2010 to 2012.
Work at INESSS
At the Institut national d'excellence en santé et en services sociaux (INESSS), Nour Drai served as a Scientific Advisor in Pharmacoeconomics for three years. During her tenure from 2018 to 2021, she was engaged in evaluating the economic aspects of pharmaceuticals and their impacts on healthcare systems in the Montreal area.
Work at Novartis
Nour Drai's experience at Novartis included responsibilities in Health Economics and Patient Access. She was with the company for 11 months from 2017 to 2018, contributing to the assessment and access strategy for healthcare products within the Montreal, Canada area.